Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration

Aim of the study was to explore the role of the FGF-23/sKlotho/sclerostin ratio disturbance in the determining of cardiovascular risk in end stage renal disease (ESRD) patients, receiving treatment with regular hemodialysis (НD) or hemodiafiltration (НDF) online in Russia. Materials and methods. 42...

Descripció completa

Dades bibliogràfiques

Autors principals:	L Yu Milovanova, I A Dobrosmyslov, Yu S Milovanov, V V Fomin, M V Taranova, V V Kozlov, S Yu Milovanova, E I Kozevnikova
Format:	Artigo
Idioma:	Russo
Publicat:	"Consilium Medicum" Publishing house 2018-06-01
Col·lecció:	Терапевтический архив
Matèries:	hyperphosphatemia fibroblast growth factor-23 (fgf-23) soluble klotho sclerostine hemodialysis hemodiafiltration troponin secondary hyperparathyroidism
Accés en línia:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32765/pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!